Phase I trial of Uracil-Tegafur (UFT) plus oral leucovorin: 14-day schedule
- 1 June 1997
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 15 (2) , 123-128
- https://doi.org/10.1023/a:1005808822565
Abstract
We previously reported results of a Phase II trial of UFT [Taiho Pharmaceutical Ltd., Tokyo, Japan; (BMS-200604) Bristol-Myers Squibb, Princeton, NJ], an oral 4:1 molar concentration of uracil and...Keywords
This publication has 15 references indexed in Scilit:
- Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.Journal of Clinical Oncology, 1994
- Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.1993
- Comprehensive Criteria for Assessing Therapy-Induced ToxicityCancer Investigation, 1989
- Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.Journal of Clinical Oncology, 1988
- CYTOTOXICITY OF FLOXURIDINE AND 5-FLUOROURACIL IN HUMAN T-LYMPHOBLAST LEUKEMIA-CELLS - ENHANCEMENT BY LEUCOVORIN1987
- [Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT].1982
- A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958)Cancer Treatment Reviews, 1980
- MECHANISM OF INDUCTION OF GASTRO-INTESTINAL TOXICITY IN THE MOUSE BY 5-FLUOROURACIL, 5-FLUOROURIDINE, AND 5-FLUORO-2'-DEOXYURIDINE1979
- EFFECT OF URACIL ON METABOLISM OF 5-FLUOROURACIL INVITRO1979
- EFFECT OF URACIL AND ITS DERIVATIVES ON ANTI-TUMOR ACTIVITY OF 5-FLUOROURACIL AND 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL1978